about
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewPrimary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trialPrevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirinAHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusionsAspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treStatins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trialThe Drug Derived Complexity Index (DDCI) Predicts Mortality, Unplanned Hospitalization and Hospital Readmissions at the Population LevelConsensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes
P50
Q26850912-B41D265E-A255-4964-AF62-A88846419858Q28166227-A85196DD-17E2-4C49-8CAC-80F3E77E1523Q28212525-295578F7-0978-446A-98D7-5DCEA756C738Q28217872-81C9DBE6-30F9-492E-A059-7CAAF6FF8583Q28220363-8EF39A8A-585F-4CFC-80A6-F868B4512529Q28481709-ED803320-AAAB-4F99-A10A-547D5494F835Q28550269-24D500AB-DD93-478D-8AD3-F3063C485E32Q28732681-A882CC5B-C7E4-43CD-BD30-EBB6F89B757E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio Nicolucci
@ast
Antonio Nicolucci
@en
Antonio Nicolucci
@es
Antonio Nicolucci
@nl
Antonio Nicolucci
@sl
type
label
Antonio Nicolucci
@ast
Antonio Nicolucci
@en
Antonio Nicolucci
@es
Antonio Nicolucci
@nl
Antonio Nicolucci
@sl
prefLabel
Antonio Nicolucci
@ast
Antonio Nicolucci
@en
Antonio Nicolucci
@es
Antonio Nicolucci
@nl
Antonio Nicolucci
@sl